Fracture incidence in HIV-infected women: results from the Women's Interagency HIV Study
- 13 November 2010
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in AIDS
- Vol. 24 (17), 2679-2686
- https://doi.org/10.1097/qad.0b013e32833f6294
Abstract
Background: The clinical importance of the association of HIV infection and antiretroviral therapy (ART) with low bone mineral density (BMD) in premenopausal women is uncertain because BMD stabilizes on established ART and fracture data are limited. Methods: We measured time to first new fracture at any site with median follow-up of 5.4 years in 2391 (1728 HIV-infected, 663 HIV-uninfected) participants in the Women's Interagency HIV Study (WIHS). Self-report of fracture was recorded at semiannual visits. Proportional hazard models assessed predictors of incident fracture. Results: At baseline, HIV-infected women were older (40 ± 9 vs. 36 ± 10 years, P < 0.0001), more likely to report postmenopausal status and be hepatitis C virus-infected, and weighed less than HIV-uninfected women. Among HIV-infected women, mean CD4+ cell count was 482 cells/μl; 66% were taking ART. Unadjusted incidence of fracture did not differ between HIV-infected and uninfected women (1.8 vs. 1.4/100 person-years, respectively, P = 0.18). In multivariate models, white (vs. African-American) race, hepatitis C virus infection, and higher serum creatinine, but not HIV serostatus, were statistically significant predictors of incident fracture. Among HIV-infected women, older age, white race, current cigarette use, and history of AIDS-defining illness were associated with incidence of new fracture. Conclusion: Among predominantly premenopausal women, there was little difference in fracture incidence rates by HIV status, rather traditional risk factors were important predictors. Further research is necessary to characterize fracture risk in HIV-infected women during and after the menopausal transition.Keywords
This publication has 31 references indexed in Scilit:
- Short-Term Bone Loss in HIV-Infected Premenopausal WomenJAIDS Journal of Acquired Immune Deficiency Syndromes, 2010
- Hip Fracture Incidence in Relation to Age, Menopausal Status, and Age at Menopause: Prospective AnalysisPLoS Medicine, 2009
- Viral hepatitis is associated with reduced bone mineral density in HIV-infected women but not menAIDS, 2009
- Continuous antiretroviral therapy decreases bone mineral densityAIDS, 2009
- Ten-year incidence and risk factors of bone fractures in a cohort of treated HIV1-infected adultsAIDS, 2009
- Fracture Prevalence among Human Immunodeficiency Virus (HIV)-InfectedVersusNon-HIV-Infected Patients in a Large U.S. Healthcare SystemJournal of Clinical Endocrinology & Metabolism, 2008
- Evolution of bone mineral density in AIDS patients on treatment with zidovudine/lamivudine plus abacavir or lopinavir/ritonavirHIV Medicine, 2007
- Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infectionAIDS, 2007
- Longitudinal Analysis of Bone Density in Human Immunodeficiency Virus-Infected WomenJournal of Clinical Endocrinology & Metabolism, 2006
- Longitudinal Evolution of Bone Mineral Density and Bone Markers in Human Immunodeficiency Virus–Infected IndividualsClinical Infectious Diseases, 2003